ID

15193

Description

DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT02312427

Lien

https://clinicaltrials.gov/show/NCT02312427

Mots-clés

  1. 22/05/2016 22/05/2016 -
Téléchargé le

22 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Heart Failure NCT02312427

Eligibility Heart Failure NCT02312427

Criteria
Description

Criteria

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes patient with congestive heart failure under treatment with dpp-4 inhibitor (sitagliptin, vildagliptin, alogliptin, linagliptin, teneligliptin, anagliptin or saxagliptin) .
Description

Diabetes Mellitus, Non-Insulin-Dependent | Congestive heart failure | Therapeutic procedure Dipeptidyl Peptidase-4 Inhibitor | sitagliptin | vildagliptin | alogliptin | Linagliptin | teneligliptin | anagliptin | saxagliptin

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0018802
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C3537225
UMLS CUI [4]
C1565750
UMLS CUI [5]
C1570906
UMLS CUI [6]
C1958126
UMLS CUI [7]
C2746078
UMLS CUI [8]
C2981308
UMLS CUI [9]
C3272640
UMLS CUI [10]
C1611934
high serum bnp (100-2000pg/ml).
Description

B-type natriuretic peptide (BNP) High

Type de données

boolean

Alias
UMLS CUI [1,1]
C2082356
UMLS CUI [1,2]
C0205250
patients who have given informed consent to participation in the study.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
hba1c over 9.0%.
Description

Glycosylated hemoglobin A

Type de données

boolean

Alias
UMLS CUI [1]
C0019018
patients who changed medication within 1 months before inclusion.
Description

Change of medication Before Inclusion

Type de données

boolean

Alias
UMLS CUI [1,1]
C0580105
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C1512693
judged as ineligible by clinical investigators.
Description

Ineligibility Judgment Clinical Investigators

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0022423
UMLS CUI [1,3]
C0008961
hospitalization arm
Description

Hospitalization Arm

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C1522541
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes patient who were hospitalized for congestive heart failure.
Description

Diabetes Mellitus, Non-Insulin-Dependent | Hospitalization Congestive heart failure

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0018802
patients who have given informed consent to participation in the study.
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients on insulin therapy.
Description

Insulin regime

Type de données

boolean

Alias
UMLS CUI [1]
C0557978
judged as ineligible by clinical investigators.
Description

Ineligibility Judgment Clinical Investigators

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0022423
UMLS CUI [1,3]
C0008961

Similar models

Eligibility Heart Failure NCT02312427

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Congestive heart failure | Therapeutic procedure Dipeptidyl Peptidase-4 Inhibitor | sitagliptin | vildagliptin | alogliptin | Linagliptin | teneligliptin | anagliptin | saxagliptin
Item
type 2 diabetes patient with congestive heart failure under treatment with dpp-4 inhibitor (sitagliptin, vildagliptin, alogliptin, linagliptin, teneligliptin, anagliptin or saxagliptin) .
boolean
C0011860 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C3537225 (UMLS CUI [3,2])
C1565750 (UMLS CUI [4])
C1570906 (UMLS CUI [5])
C1958126 (UMLS CUI [6])
C2746078 (UMLS CUI [7])
C2981308 (UMLS CUI [8])
C3272640 (UMLS CUI [9])
C1611934 (UMLS CUI [10])
B-type natriuretic peptide (BNP) High
Item
high serum bnp (100-2000pg/ml).
boolean
C2082356 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
Informed Consent
Item
patients who have given informed consent to participation in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Glycosylated hemoglobin A
Item
hba1c over 9.0%.
boolean
C0019018 (UMLS CUI [1])
Change of medication Before Inclusion
Item
patients who changed medication within 1 months before inclusion.
boolean
C0580105 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,3])
Ineligibility Judgment Clinical Investigators
Item
judged as ineligible by clinical investigators.
boolean
C1512714 (UMLS CUI [1,1])
C0022423 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])
Hospitalization Arm
Item
hospitalization arm
boolean
C0019993 (UMLS CUI [1,1])
C1522541 (UMLS CUI [1,2])
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Hospitalization Congestive heart failure
Item
type 2 diabetes patient who were hospitalized for congestive heart failure.
boolean
C0011860 (UMLS CUI [1])
C0019993 (UMLS CUI [2,1])
C0018802 (UMLS CUI [2,2])
Informed consent
Item
patients who have given informed consent to participation in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Insulin regime
Item
patients on insulin therapy.
boolean
C0557978 (UMLS CUI [1])
Ineligibility Judgment Clinical Investigators
Item
judged as ineligible by clinical investigators.
boolean
C1512714 (UMLS CUI [1,1])
C0022423 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial